BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mettelman RC, Allen EK, Thomas PG. Mucosal immune responses to infection and vaccination in the respiratory tract. Immunity 2022;55:749-80. [PMID: 35545027 DOI: 10.1016/j.immuni.2022.04.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Bjornsdottir B, Benitez Hernandez U, Haraldsson A, Thors V. Febrile Children with Pneumonia Have Higher Nasopharyngeal Bacterial Load Than Other Children with Fever. Pathogens 2023;12:517. [DOI: 10.3390/pathogens12040517] [Reference Citation Analysis]
2 Moore KA, Leighton T, Ostrowsky JT, Anderson CJ, Danila RN, Ulrich AK, Lackritz EM, Mehr AJ, Baric RS, Baylor NW, Gellin BG, Gordon JL, Krammer F, Perlman S, Rees HV, Saville M, Weller CL, Osterholm MT; Coronavirus Vaccines R&D Roadmap Taskforce. A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy. Vaccine 2023;41:2101-12. [PMID: 36870874 DOI: 10.1016/j.vaccine.2023.02.032] [Reference Citation Analysis]
3 He X, Chen X, Wang H, Du G, Sun X. Recent advances in respiratory immunization: A focus on COVID-19 vaccines. J Control Release 2023;355:655-74. [PMID: 36787821 DOI: 10.1016/j.jconrel.2023.02.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Higham SL, Baker S, Flight KE, Krishna A, Kellam P, Reece ST, Tregoning JS. Intranasal immunisation with Outer Membrane Vesicles (OMV) protects against airway colonisation and systemic infection with Acinetobacter baumannii. J Infect 2023:S0163-4453(23)00122-6. [PMID: 36858180 DOI: 10.1016/j.jinf.2023.02.035] [Reference Citation Analysis]
5 Zhu B, Wei X, Narasimhan H, Qian W, Zhang R, Cheon IS, Wu Y, Li C, Jones RG, Kaplan MH, Vassallo RA, Braciale TJ, Somerville L, Colca JR, Pandey A, Jackson PEH, Mann BJ, Krawczyk CM, Sturek JM, Sun J. Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19. Sci Immunol 2023;:eadf0348. [PMID: 36821695 DOI: 10.1126/sciimmunol.adf0348] [Reference Citation Analysis]
6 Kasumba DM, Huot S, Caron E, Fortin A, Laflamme C, Zamorano Cuervo N, Lamontagne F, Pouliot M, Grandvaux N. DUOX2 regulates secreted factors in virus-infected respiratory epithelial cells that contribute to neutrophil attraction and activation. FASEB J 2023;37:e22765. [PMID: 36607642 DOI: 10.1096/fj.202201205R] [Reference Citation Analysis]
7 Jangra S, Landers J, Laghlali G, Rathnasinghe R, O'Konek J, Janczak K, Garcia-Sastre A, Baker J, Schotsaert M, Wong P. A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice. Res Sq 2023:rs. [PMID: 36711479 DOI: 10.21203/rs.3.rs-2457013/v1] [Reference Citation Analysis]
8 Malarvili M, Howe TA, Ramanathan S, Alexie M, Singh OP. Design of carbon dioxide measurement device for asthma monitoring. Systems and Signal Processing of Capnography as a Diagnostic Tool for Asthma Assessment 2023. [DOI: 10.1016/b978-0-323-85747-5.00009-7] [Reference Citation Analysis]
9 Caulfield AD, Callender M, Harvill ET. Generating enhanced mucosal immunity against Bordetella pertussis: current challenges and new directions. Front Immunol 2023;14:1126107. [PMID: 36895562 DOI: 10.3389/fimmu.2023.1126107] [Reference Citation Analysis]
10 Pascual DW, Goodwin ZI, Bhagyaraj E, Hoffman C, Yang X. Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis. Front Microbiol 2022;13:1018165. [PMID: 36620020 DOI: 10.3389/fmicb.2022.1018165] [Reference Citation Analysis]
11 Brook B, Fatou B, Checkervarty A, Barman S, Sweitzer C, Bosco AN, Sherman A, Baden LR, Morrocchi E, Sanchez-Schmitz G, Palma P, Nanishi E, O'Meara T, McGrath M, Frieman M, Soni D, van Haren S, Ozonoff A, Diray-Arce J, Steen H, Dowling D, Levy O. The mRNA vaccine BNT162b2 demonstrates impaired TH1 immunogenicity in human elders in vitro and aged mice in vivo. Res Sq 2022:rs. [PMID: 36597547 DOI: 10.21203/rs.3.rs-2395118/v1] [Reference Citation Analysis]
12 Alavi M, Mozafari MR, Ghaemi S, Ashengroph M, Hasanzadeh Davarani F, Mohammadabadi M. Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study. Biomedicines 2022;10. [PMID: 36551830 DOI: 10.3390/biomedicines10123074] [Reference Citation Analysis]
13 Sengupta A, Al-otaibi N, Devito C, Lottersberger F, Hinkula J. Characterization of splenic and systemic immunity by differentially charged lipid adjuvants in enhancing post-intranasal immunization response against influenza.. [DOI: 10.21203/rs.3.rs-2210670/v1] [Reference Citation Analysis]
14 Karamchand L, Makeiff D, Gao Y, Azyat K, Serpe MJ, Kulka M. Biomaterial inks and bioinks for fabricating 3D biomimetic lung tissue: A delicate balancing act between biocompatibility and mechanical printability. Bioprinting 2022. [DOI: 10.1016/j.bprint.2022.e00255] [Reference Citation Analysis]
15 Baklaushev VP, Yusubalieva GM, Bychinin MV, Yusubalieva SM, Kalsin VA, Troitskiy AV. A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains. Journal of Clinical Practice 2022;13:43-55. [DOI: 10.17816/clinpract111120] [Reference Citation Analysis]
16 Sengupta A, Azharuddin M, Johanna E, Daniel A, Selegård R, Naeimipour S, von Castelmur E, Wahlin A, Sunnerhagen M, Pietras Z, Patra HK, Al-otaibi N, Sigvardsson M, Håkan H, Katarina N, Östholm-balkhed Å, Hinkula J. Long-term systemic and mucosal humoral response in SARS- CoV-2 vaccinated post-Covid-19 infected patients.. [DOI: 10.21203/rs.3.rs-2113175/v1] [Reference Citation Analysis]
17 Zhang L, Jiang Y, He J, Chen J, Qi R, Yuan L, Shao T, Chen C, Chen Y, Wang X, Lei X, Gao Q, Zhuang C, Zhou M, Ma J, Liu W, Yang M, Fu R, Wu Y, Chen F, Xiong H, Nie M, Chen Y, Wu K, Fang M, Wang Y, Zheng Z, Huang S, Ge S, Cheng SC, Zhu H, Cheng T, Yuan Q, Wu T, Zhang J, Chen Y, Zhang T, Qi H, Guan Y, Xia N. Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response.. [DOI: 10.1101/2022.10.03.510566] [Reference Citation Analysis]
18 Sengupta A, Al-otaibi N, Devito C, Lottersberger F, Hinkula J. Anionic and Cationic Lipid Adjuvants individually induce distinct adaptive Th1/Th2-type immunity in enhancing post-intranasal immunization response against influenza.. [DOI: 10.21203/rs.3.rs-2037306/v1] [Reference Citation Analysis]
19 Grebennikov D, Karsonova A, Loguinova M, Casella V, Meyerhans A, Bocharov G. Predicting the Kinetic Coordination of Immune Response Dynamics in SARS-CoV-2 Infection: Implications for Disease Pathogenesis. Mathematics 2022;10:3154. [DOI: 10.3390/math10173154] [Reference Citation Analysis]
20 Parriott JE, Stewart JP, Smith DD, Curran SM, Bauer CD, Wyatt TA, Phillips JA, Lyden E, Thiele GM, Vetro JA. Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization. Pharmaceutics 2022;14:1843. [DOI: 10.3390/pharmaceutics14091843] [Reference Citation Analysis]
21 Cheng X, Ning J, Xu X, Zhou X. The role of bacterial cyclic di-adenosine monophosphate in the host immune response. Front Microbiol 2022;13:958133. [DOI: 10.3389/fmicb.2022.958133] [Reference Citation Analysis]
22 Dong J, Zhou Y, Pu J, Liu L. Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China. Life 2022;12:1326. [DOI: 10.3390/life12091326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Nouailles G, Adler JM, Pennitz P, Peidli S, Alves GT, Baumgart M, Bushe J, Voss A, Langenhagen A, Pott F, Kazmierski J, Goekeri C, Simmons S, Xing N, Langner C, Vidal RM, Abdelgawad A, Herwig S, Cichon G, Niemeyer D, Drosten C, Goffinet C, Landthaler M, Blüthgen N, Wu H, Witzenrath M, Gruber AD, Praktiknjo SD, Osterrieder N, Wyler E, Kunec D, Trimpert J. A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants.. [DOI: 10.1101/2022.05.16.492138] [Reference Citation Analysis]
24 Stolovich-Rain M, Kumari S, Friedman A, Kirillov S, Socol Y, Billan M, Pal RR, Das K, Golding P, Oiknine-Djian E, Sirhan S, Sagie MB, Cohen-Kfir E, Gold N, Fahoum J, Kumar M, Elgrably-Weiss M, Zhou B, Ravins M, Gatt YE, Bhattacharya S, Zelig O, Wiener R, Wolf DG, Elinav H, Strahilevitz J, Padawer D, Baraz L, Rouvinski A. Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgA. Front Immunol 2022;13:933347. [PMID: 36798518 DOI: 10.3389/fimmu.2022.933347] [Reference Citation Analysis]